ICD-10-CM Billable Code

A69.22

Other neurologic disorders in Lyme disease

Clinical Classification Guidelines

Inclusion Terms

  • Cranial neuritis
  • Meningoencephalitis
  • Polyneuropathy

Medical Intelligence & Overview

Lyme disease is a bacterial infection transmitted through tick bites, which can affect various parts of the body. While many associate it with skin rashes and flu-like symptoms, Lyme disease can also cause neurological problems. When these neurological issues occur, they are categorized under ICD-10 code A69.22, labeled as 'Other neurologic disorders in Lyme disease.' These conditions can include inflammation or dysfunction of nerve tissues, impacting the nervous system's normal operation. Recognizing the neurological implications of Lyme disease is essential for understanding its full spectrum of effects and ensuring comprehensive care.

Causes & Symptoms

Clinical Causes: Lyme disease bacteria (Borrelia burgdorferi) invading nervous tissue Spread of infection to the central and peripheral nervous systems Inflammatory responses triggered by the immune system's reaction to bacteria Delayed or inadequate treatment of initial Lyme disease infection Potential co-infections transmitted through the same tick bite that can complicate neurological health

Key Symptoms: Cranial nerve inflammation leading to facial paralysis or weakness Headaches and neck stiffness due to meningoencephalitis Numbness, tingling, or burning sensations from polyneuropathy Dizziness or imbalance related to nerve involvement Cognitive difficulties such as memory problems or confusion Muscle weakness or paralysis in affected limbs Sensitivity to light and sound in cases of meningeal irritation

Diagnostic & Treatment

Diagnosis Path: Diagnosis of neurological disorders in Lyme disease involves a combination of clinical evaluation and laboratory tests. Healthcare providers may review patient history of tick exposure and symptoms, alongside neurological examinations. Laboratory analysis typically includes blood tests for specific antibodies to Borrelia burgdorferi and sometimes cerebrospinal fluid analysis obtained through a lumbar puncture. Imaging studies like MRI may be used to assess internal brain and nerve structures. Since these neurological conditions can mimic other disorders, a comprehensive assessment is essential for accurate diagnosis.

Treatment Protocols: Treatment strategies focus primarily on eliminating the infection and reducing inflammation. Antibiotic therapy remains the mainstay, often involving medications such as doxycycline, ceftriaxone, or penicillin, depending on severity and specific neurological involvement. Duration of treatment varies based on individual patient response and the extent of neurological symptoms. Supportive care options include physical therapy to address nerve damage or weakness, and medications to manage pain or inflammation. Prompt treatment improves recovery chances and prevents long-term complications.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is A69.22 a billable ICD-10 code?
Yes, A69.22 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report A69.22?
Clinical documentation must specify the nature of Other neurologic disorders in Lyme disease and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

disease disorders neurologic